REQUIP (nda020658)- (EQ 0.25MG BASE,EQ 0.5MG BASE,EQ 1MG BASE,EQ 2MG BASE,EQ 5MG BASE,EQ 3MG BASE,EQ 4MG BASE)

Generic Name	ROPINIROLE HYDROCHLORIDE	Innovator	GLAXOSMITHKLINE LLC
Dosage	EQ 0.25MG BASE,EQ 0.5MG BASE,EQ 1MG BASE,EQ 2MG BASE,EQ 5MG BASE,EQ 3MG BASE,EQ 4MG BASE
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	2008-May-19	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	REQUIP is a non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS).

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
9	0	8

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 0.25MG BASE	**	**	-	-	4
EQ 0.5MG BASE	**	**	-	-	4
EQ 1MG BASE	**	**	-	-	4
EQ 2MG BASE	**	**	-	-	4
EQ 5MG BASE	**	**	-	-	4
EQ 3MG BASE	**	**	-	-	4
EQ 4MG BASE	**	**	-	-	4

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	6

Manufacturing Details of REQUIP